Company name
Fundacion Butantan
Project number
13680-01
Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.
E&S category
B
Country
Brazil
Sector
N/A
Status
In implementation
Disclosed date
09/30/2022
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
12/06/2022
Approval date
12/06/2022
Signed date
12/14/2022
Sponsoring entity
N/A
Investment Operations Department Contact
Portfolio Management Division
Investment type
Syndicated amount
USD $ 100,000,000
Financing amount
USD $ 62,000,000
Currency
BRL
Project scope and objective
The purpose of the operation with Fundação Butantan (“Client” or “Butantan”) is to finance the construction of two new pharmaceutical manufacturing and processing units: i) the Egg-based Vaccine Research Center (“CPVO II”), which consists of an Influenza vaccine manufacturing plant; and ii) the Final Processing Center for Immunobiologicals (“CPFI”), which consists of a plant for formulating, filling, lyophilizing, crimping, labeling, and packaging pharmaceutical products (“Project”).
The operation will be structured in the form of a loan, with a final term of 10 years, including a 3-year grace period. The project will be developed in the City of São Paulo, Brazil, at the same location where Fundação Butantan currently operates.
Addendum: On November 7, a revised version is uploaded for the Environmental and Social Impact Study.
For inquiries, comments and information requests about the project
Request informationLearn more about how we provide private-sector solutions in the region .
Contact information
For inquiries, comments and information requests about the project
Request informationAlternatively, you may also use the following contact information :
Client Contact
cristiano.goncalves@butantan.gov.br
PHONE NUMBER
+55-11-2627-9300
POST OFFICE ADDRESS
IDB Invest Contact
requestinformation@idbinvest.org
PHONE
+1(202)-566-4566
ADDRESS
1350 New York Ave NW, Washington, DC 20005
COUNTRY OFFICES
IDB Invest Country OfficesFor inquiries, comments and information requests about the project
Request informationLearn more about how we provide private-sector solutions in the region .
Environmental and social review
IDB Invest conducts an environmental and social due diligence (ESDD) commensurate with the nature, scale, and stage of the project, and with its level of environmental and social risks and impacts. The ESDD will confirm the project E&S categorization and assess the project with respect to the client requirements in IDB Invest Environmental and Social Sustainability Policy. The results of the ESDD, including any identified gaps are described in the Environmental and Social Review Summary (ESRS) provided below. For projects approved as of 2016, any gaps with respect to IDB Invest's Environmental and Social Sustainability Policy at the time of the ESDD are addressed in the Environmental and Social Action Plan (ESAP) presented below, to comply with the date mentioned above.
BUTANTAN ENVIRONMENTAL AND SOCIAL REVIEW SUMMARY (ESRS)
860.2 Kb
BUTANTAN ENVIRONMENTAL AND SOCIAL ACTION PLAN (ESAP)
348.2 Kb
BUTANTAN - CLARIFICATION NOTE
501.8 Kb
BUTANTAN ENVIRONMENTAL AND SOCIAL ACTION PLAN (ESAP) - REV 1
358.4 Kb